Monistat, Oravig, Vfend (miconazole) is a small molecule pharmaceutical. Miconazole was first approved as Monistat on 1982-01-01. It is used to treat aspergillosis, cutaneous candidiasis, mycoses, tinea pedis, and tinea versicolor amongst others in the USA. It has been approved in Europe to treat aspergillosis, bacterial infections and mycoses, candidiasis, and mycoses. It is known to target transient receptor potential cation channel subfamily M member 2 and transient receptor potential cation channel subfamily V member 5. Miconazole nitrate's patent is valid until 2022-09-11 (FDA).
|Indication||aspergillosis, bacterial infections and mycoses, candidiasis, cutaneous candidiasis, mycoses, tinea pedis, tinea versicolor, vulvovaginal candidiasis|
|Drug Class||Systemic antifungals (miconazole type)|